An appeal from Marburg
According to the Frankfurter Allgemeine Zeitung, in the struggle to save the future of BioNTech’s Marburg plant, Mayor Thomas Spies of the Social Democratic Party (SPD) has appealed to the federal and state governments. In his view, the plant and the entire pharmaceutical site matter far beyond the region.
…jeopardizes Europe’s security of supply and resilience to crises.
Spies, who worked as a physician before entering politics, said the federal and state governments must quickly create reliable conditions to secure existing production capacity and the associated expertise, as a precaution against possible future pandemics.
A closure decision after no buyer was found
On September 28, BioNTech confirmed it would close three plants in Germany after a months-long search for buyers failed. Key details include:
- The Tübingen plant, former headquarters of CureVac, which BioNTech acquired, will close at the end of 2027; Marburg in early 2028 and Idar-Oberstein at the end of 2028.














